Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans & Pricing
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
ABBV
Stock Latest News
Company Announcements
AbbVie’s HIV Treatment Study Update: Key Insights for Investors
7h ago
ABBV
Premium
The Fly
AbbVie reports results from Phase 3 studies evaluating upadacitinib
11h ago
ABBV
Premium
Pre-Earnings
ABBV Earnings this Week: How Will it Perform?
14h ago
ABBV
Premium
Company Announcements
AbbVie’s Latest Study on JUVÉDERM: What Investors Need to Know
2d ago
ABBV
Premium
Company Announcements
AbbVie’s Mass Balance Study of ABBV-1354: Key Insights for Investors
2d ago
ABBV
Premium
Company Announcements
AbbVie Advances with Emraclidine Study in Elderly: A Potential Game Changer?
2d ago
ABBV
Premium
Company Announcements
AbbVie’s New Study on ELAPR002f Gel: A Potential Game-Changer for Acne Scars
2d ago
ABBV
Premium
Company Announcements
AbbVie’s New Phase 2 Study Targets MET Amplification in Solid Tumors
2d ago
ABBV
Premium
Company Announcements
AbbVie’s Promising Study on ABBV-6628 for Geographic Atrophy: What Investors Need to Know
2d ago
ABBV
Premium
Company Announcements
AbbVie’s Cariprazine Study: A New Chapter in Pediatric Treatment
2d ago
ABBV
Premium
Company Announcements
AbbVie’s ABBV-303 Study Terminated: Implications for Investors
2d ago
ABBV
Premium
Company Announcements
AbbVie’s Fosigotifator Study Termination: Impact on MDD Treatment Pipeline
2d ago
ABBV
Premium
Company Announcements
AbbVie Withdraws Study on Hair Loss in Oriahnn Users: Market Implications
2d ago
ABBV
Premium
Company Announcements
AbbVie’s AML Study Termination: Implications for Investors
2d ago
ABBV
Premium
Company Announcements
AbbVie’s Elagolix Pregnancy Study Terminated: Market Implications
2d ago
ABBV
Premium
Market News
Options Volatility and Implied Earnings Moves This Week, October 28 – October 31, 2025
2d ago
V
BA
Premium
The Fly
Avidity Biosciences downgraded to Neutral from Buy at Roth Capital
2d ago
LLY
MRK
Premium
Company Announcements
AbbVie’s ABBV-932 Study: A New Hope for Bipolar Disorder Treatment?
5d ago
ABBV
Premium
Company Announcements
AbbVie’s Upadacitinib Study Completes: Promising Results for Atopic Dermatitis
5d ago
ABBV
Premium
Ratings
AbbVie Hold Rating: Balancing Strong Performance with Emerging Challenges
5d ago
ABBV
Premium
Company Announcements
AbbVie’s Atogepant Study: A Step Forward in Migraine Prevention
8d ago
ABBV
Premium
The Fly
AbbVie reports ‘positive’ results from Phase 3b/4 SELECT-SWITCH study
9d ago
ABBV
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.